Bristol Myers Squibb and Microsoft have launched a digital health collaboration aimed at accelerating early detection of lung cancer using AI-driven radiology workflows.
The initiative will deploy FDA-cleared algorithms through Microsoft’s Precision Imaging Network, which is used by more than 80% of U.S. hospitals, according to a Jan. 16 news release from Bristol Myers Squibb. The workflow management tools are analyze X-ray and CT images, help detect lung nodules and identify early-stage disease, and support patient tracking through care pathways.
The collaboration aims to reduce diagnostic delays, improve operational efficiency and expand early detection access in medically underserved communities, including rural clinics.
Leaders said the partnership leverages Bristol Myers Squibb’s oncology expertise and Microsoft’s AI infrastructure.
